Literature DB >> 2627140

Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma.

M M Jones1, M A Basinger.   

Abstract

An examination of eighteen thiols and thio ethers revealed that the simultaneous administration of several of these with cis-platinum (CDDP) at 7.5 mg/kg (25 mumols/kg) iv, as a single injection to rats bearing the Walker 256 carcinosarcoma led to significant reduction in the nephrotoxicity typically found with cis-platinum, and no apparent interference in its anti-neoplastic action towards this tumor. The thiols and thiol ethers were administered at a twenty-fold molar excess to the CDDP and were combined with the CDDP immediately prior to administration. The most effective compounds in suppression nephrotoxicity were D-, and L-methionine, methyl and ethyl L-methioninate, and N-acetyl-D, L-methionine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2627140

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  D-methionine protects against cisplatin-induced neurotoxicity in the hippocampus of the adult rat.

Authors:  Sneha Hinduja; Kari Suzanne Kraus; Senthilvelan Manohar; Richard J Salvi
Journal:  Neurotox Res       Date:  2014-12-09       Impact factor: 3.911

2.  Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.

Authors:  D J Stewart; C Dulberg; J M Molepo; N Z Mikhael; V A Montpetit; M D Redmond; R Goel
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model.

Authors:  P Giordano; G Lorito; A Ciorba; A Martini; S Hatzopoulos
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-08       Impact factor: 2.124

Review 4.  WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.

Authors:  M Treskes; W J van der Vijgh
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 5.  Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy.

Authors:  Melani Sooriyaarachchi; Graham N George; Ingrid J Pickering; Aru Narendran; Jürgen Gailer
Journal:  Metallomics       Date:  2016-11-09       Impact factor: 4.526

6.  Protective Effect of D-Methionine on Body Weight Loss, Anorexia, and Nephrotoxicity in Cisplatin-Induced Chronic Toxicity in Rats.

Authors:  Ming-Tai Lin; Jiunn-Liang Ko; Te-Chung Liu; Pei-Tsen Chao; Chu-Chyn Ou
Journal:  Integr Cancer Ther       Date:  2018-02-11       Impact factor: 3.279

Review 7.  Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss.

Authors:  Robert A Hazlitt; Jaeki Min; Jian Zuo
Journal:  J Med Chem       Date:  2018-02-01       Impact factor: 7.446

8.  Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study.

Authors:  Raju Bandu; Hyun Soo Ahn; Joon Won Lee; Yong Woo Kim; Seon Hee Choi; Hak Jin Kim; Kwang Pyo Kim
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.